1. Show article details.

    Mesa Labs Closes Acquisition of Agena Bioscience

    GlobeNewswire – 12:05 PM ET 10/20/2021

    Mesa Laboratories, Inc. (MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc. With this highly strategic acquisition, Agena’s innovative approach to molecular diagnostics is now paired with Mesa’s proven approach to continuous improvement and operational and commercial efficiency.

  2. Show article details.

    Mesa Labs Declares Quarterly Dividend

    GlobeNewswire – 3:00 PM ET 10/01/2021

    Mesa Laboratories, Inc. (MLAB) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare and medical device industries. Forward Looking Statements.

  3. Show article details.

    BRIEF-Mesa Labs To Buy Agena Bioscience For $300 Million

    Reuters – 7:28 AM ET 09/14/2021

    Mesa Laboratories Inc (MLAB): * MESA LABS ANNOUNCES AGREEMENT TO ACQUIRE AGENA BIOSCIENCE, INC. * Mesa Laboratories Inc (MLAB) - DEAL FOR $300 MILLION. * Mesa Laboratories Inc (MLAB) - EXPECTS TO FINANCE ALL-CASH TRANSACTION WITH A COMBINATION OF CASH ON HAND AND PROCEEDS FROM OUR CREDIT FACILITY Source text for Eikon: Further company coverage:

  4. Show article details.

    Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

    GlobeNewswire – 7:00 AM ET 09/14/2021

    Mesa Laboratories, Inc. (MLAB), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments.

  5. Show article details.

    BRIEF-Mesa Labs Announces First Quarter Results

    Reuters – 10:21 AM ET 08/05/2021

    Mesa Laboratories Inc (MLAB): * MESA LABS ANNOUNCES FIRST QUARTER RESULTS. * Q1 ADJUSTED OPERATING EARNINGS PER SHARE $1.72 EXCLUDING ITEMS. * QTRLY NET INCOME $0.38 PER SHARE. * QTRLY ADJUSTED OPERATING INCOME $1.72 PER SHARE. * QTRLY REVENUE $34.9 MILLION VERSUS $29.9 MILLION Source text for Eikon: Further company coverage:

  6. Show article details.

    Mesa Labs Announces First Quarter Results

    GlobeNewswire – 8:00 AM ET 08/05/2021

    Mesa Laboratories, Inc. (MLAB) today reported results for its first fiscal quarter.

  7. Show article details.

    MESA LABS DECLARES QUARTERLY DIVIDEND

    GlobeNewswire – 7:19 PM ET 07/06/2021

    Mesa Laboratories, Inc. (MLAB) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. About Mesa Laboratories, Inc. (MLAB) Mesa Labs (MLAB) is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries.

  8. Show article details.

    Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

    GlobeNewswire – 8:00 AM ET 06/01/2021

    Mesa Laboratories, Inc. (MLAB) today announced results for the fourth quarter and full year ended March 31, 2021.

Page:

Today's and Upcoming Events

  • Nov
    29

    MLAB ex-Dividend for $0.16 on 11/29/2021

    • Announce Date: 10/01/2021
    • Record Date: 11/30/2021
    • Pay Date: 12/15/2021
  • Nov
    03

    MLAB to announce Q2 earnings (Unconfirmed)

Past Events (last 90 days)

  • Aug
    30

    MLAB ex-Dividend for $0.16 on 08/30/2021

    • Announce Date: 07/07/2021
    • Record Date: 08/31/2021
    • Pay Date: 09/15/2021
  • Aug
    05

    MLAB announced Q1 earnings.

Data provided by Thomson Reuters © 2021

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.